Understanding the Mechanism: How Does Selumetinib Work?
•
3 min read
In 2020, selumetinib received FDA approval as the first effective treatment for children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs). But beyond its clinical success, a critical question remains: **how does selumetinib work** at a molecular level to produce these therapeutic effects?
